PARK SURGERY — All Prescriptions & Medications — Page 9
Practice Code: H82039 | LITTLEHAMPTON, BN17 6BF
Showing results 401-450 of 636
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 43 | 176 | £1.4K | +54.5% ▲ | |
| Alfuzosin hydrochloride | 42 | 2,464 | £728 | -41.3% ▼ |
| 42 | 630 | £334 | -2.6% ▼ | |
| Colesevelam hydrochloride | 41 | 7,380 | £2.8K | +8.1% ▲ |
| Estradiol valerate | 41 | 3,808 | £316 | +109.9% ▲ |
| 41 | 41 | £131 | +26.5% ▲ | |
| Desloratadine | 40 | 1,660 | £141 | +38.7% ▲ |
| Ivermectin | 40 | 281 | £3.5K | +309.9% ▲ |
| Sodium feredetate | 40 | 10.3K | £292 | +39.7% ▲ |
| Phenazone/lidocaine | 40 | 600 | £339 | +291.1% ▲ |
| Bezafibrate | 39 | 2,598 | £484 | -27.6% ▼ |
| Clonidine hydrochloride | 39 | 5,209 | £491 | -26.9% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 39 | 74.0K | £2.2K | +46.8% ▲ |
| Brimonidine tartrate | 39 | 255 | £113 | -2.3% ▼ |
| Brinzolamide and timolol | 39 | 330 | £444 | +3.2% ▲ |
| 39 | 3,440 | £410 | -19.1% ▼ | |
| 38 | 3,889 | £6.4K | +115.5% ▲ | |
| 38 | 280 | £617 | +160.2% ▲ | |
| 38 | 3,160 | £2.3K | +14.9% ▲ | |
| Dipyridamole | 37 | 3,300 | £688 | +44.1% ▲ |
| Phenytoin sodium | 37 | 3,708 | £485 | -54.2% ▼ |
| Ciprofloxacin | 37 | 754 | £83 | -7.2% ▼ |
| Norethisterone | 37 | 1,662 | £283 | -23.7% ▼ |
| Mefenamic acid | 37 | 1,457 | £268 | -18.1% ▼ |
| Acetazolamide | 37 | 3,752 | £144 | +70.8% ▲ |
| 37 | 37 | £39 | -83.2% ▼ | |
| 37 | 49 | £6.7K | +3.6% ▲ | |
| 37 | 1,560 | £670 | -52.2% ▼ | |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 36 | 252 | £149 | +127.6% ▲ |
| Combined ethinylestradiol 20mcg | 36 | 2,166 | £882 | -31.1% ▼ |
| Leuprorelin acetate | 36 | 36 | £7.2K | -22.3% ▼ |
| Ferrous gluconate | 36 | 1,528 | £43 | -24.7% ▼ |
| Tafluprost | 36 | 1,800 | £732 | +94.2% ▲ |
| Tacrolimus | 36 | 1,320 | £1.0K | -33.2% ▼ |
| 36 | 5,045 | £81 | +113.1% ▲ | |
| Nizatidine | 35 | 2,082 | £1.0K | +1.7% vs avg |
| Bempedoic acid/Ezetimibe | 35 | 1,680 | £3.2K | -42.7% ▼ |
| Rotigotine | 35 | 1,176 | £4.8K | +29.7% ▲ |
| Denosumab | 35 | 35 | £6.4K | +28.6% ▲ |
| Metronidazole | 35 | 1,510 | £506 | -6.9% ▼ |
| Acamprosate calcium | 34 | 1,932 | £218 | -2.4% ▼ |
| 34 | 369 | £3.3K | +93.5% ▲ | |
| 34 | 510 | £701 | +210.6% ▲ | |
| 34 | 85 | £180 | +40.3% ▲ | |
| Glycopyrronium/formoterol | 33 | 33 | £1.0K | +30.4% ▲ |
| Amantadine hydrochloride | 33 | 1,540 | £387 | +18.5% ▲ |
| Alprostadil | 33 | 128 | £1.4K | +93.0% ▲ |
| Cyproterone acetate | 33 | 1,029 | £1.4K | +200.6% ▲ |
| Leflunomide | 33 | 990 | £58 | -12.8% ▼ |
| Chlorhexidine gluconate | 33 | 12.0K | £247 | +11.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.